Oliveira, Julia Lima de; Milan, Thais Moré; Trevisan, Rayana Longo Bighetti 
; Fernandes, Roger Rodrigo ; Leopoldino, Andréia Machado ; Almeida, Luciana Oliveira de
Fonte: Oral Diseases. Unidades: FORP, FCFRP
Assuntos: REPROGRAMAÇÃO NUCLEAR, NEOPLASIAS DE CABEÇA E PESCOÇO, QUIMIOTERÁPICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Julia Lima de et al. Epithelial–mesenchymal transition and cancer stem cells: a route to acquired cisplatin resistance through epigenetics in HNSCC. Oral Diseases, 2023Tradução . . Disponível em: https://doi.org/10.1111/odi.14209. Acesso em: 07 out. 2024.APA
Oliveira, J. L. de, Milan, T. M., Trevisan, R. L. B., Fernandes, R. R., Leopoldino, A. M., & Almeida, L. O. de. (2023). Epithelial–mesenchymal transition and cancer stem cells: a route to acquired cisplatin resistance through epigenetics in HNSCC. Oral Diseases. doi:10.1111/odi.14209NLM
Oliveira JL de, Milan TM, Trevisan RLB, Fernandes RR, Leopoldino AM, Almeida LO de. Epithelial–mesenchymal transition and cancer stem cells: a route to acquired cisplatin resistance through epigenetics in HNSCC [Internet]. Oral Diseases. 2023 ;[citado 2024 out. 07 ] Available from: https://doi.org/10.1111/odi.14209Vancouver
Oliveira JL de, Milan TM, Trevisan RLB, Fernandes RR, Leopoldino AM, Almeida LO de. Epithelial–mesenchymal transition and cancer stem cells: a route to acquired cisplatin resistance through epigenetics in HNSCC [Internet]. Oral Diseases. 2023 ;[citado 2024 out. 07 ] Available from: https://doi.org/10.1111/odi.14209
